XNCR vs ANAB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ANAB Captures Institutional Edge (2โ2 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AnaptysBio, Inc. Common Stock (ANAB) driven by superior Valuation, Growth & Margin while XNCR counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, XNCR trades at 68.0x Forward P/E with -72.7% operating margin (+454.9% YoY revenue) versus ANAB at 10.1x Forward P/E and 15.0% operating margin (-60.3% YoY). In options structure, XNCR sits in BREAKOUT (10th %ile IV; Dealer Gamma Walls on Pro) against ANAB sits in BREAKDOWN (19th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | XNCR Revenue | ANAB Revenue | XNCR Op. Margin | ANAB Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $40M | $10M | -195.5% | -1334.4% | XNCR |
| FY2019 | $160M | $10M | 8.8% | -1342.9% | XNCR |
| FY2020 | $120M | $70M | -62.6% | -31.8% | ANAB |
| FY2021 | $280M | $60M | 15.9% | -89.9% | XNCR |
| FY2022 | $160M | $10M | -50.1% | -1119.4% | XNCR |
| FY2023 | $170M | $20M | -75.8% | -958.3% | XNCR |
| FY2024 | $110M | $90M | -161.5% | 72.5% | ANAB |
| FY2025 | $130M | $230M | -141.4% | 96.7% | ANAB |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | XNCR | ANAB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.9B | $1.4B | Larger Scale | XNCR |
| Trailing P/E Ratio Valuation | 68.0x | 19.7x | Lower Multiple | ANAB |
| Forward P/E Ratio Valuation | 68.0x | 10.1x | Lower Multiple | ANAB |
| Revenue Growth (YoY) Growth | +454.9% | -60.3% | Higher Growth | XNCR |
| Operating Margin (TTM) Profitability | -72.7% | 15.0% | Higher Margin | ANAB |
| Net Profit Margin Profitability | -58.8% | 417.6% | Higher Margin | ANAB |
| Return on Equity (ROE) Capital Efficiency | -19.9% | -114.5% | Higher ROE | XNCR |
| 52-Week Range Position Momentum | 84% ($10โ$41) | 30% ($33โ$73) | Stronger Trend | XNCR |
| Beta / 30D Volatility Risk Regime | 1.21ฮฒ ยท 87% Vol | 1.08ฮฒ ยท 46% Vol | Lower Realized Risk | ANAB |
| Unified Institutional Score Composite Signal | 29.6 / 100 (SELL) | 46.7 / 100 (HOLD) | Higher Composite | ANAB |